Titan Pharmaceuticals
TTNP
#11028
Rank
โ‚ฌ5.47 M
Marketcap
4,12ย โ‚ฌ
Share price
-3.76%
Change (1 day)
19.85%
Change (1 year)

Operating Margin for Titan Pharmaceuticals (TTNP)

Operating Margin as of November 2026 (TTM): -556,900.00%

According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -556,900.00%. At the end of 2021 the company had an Operating Margin of -575.10%.

Operating Margin history for Titan Pharmaceuticals from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-575.10%275.63%
2020-153.10%-66.41%
2019-455.77%198.58%
2018-152.65%-97.71%
2017-6,654.42%-19622.65%
201634.09%-105.05%
2015-674.99%924.13%
2014-65.91%-171.13%
201392.65%-143.44%
2012-213.29%-17.41%
2011-258.26%332.63%
2010-59.69%-99.19%
2009-7,360.76%
2007-76,804.17%49.43%
2006-51,396.88%98.44%
2005-25,900.00%-68.66%
2004-82,648.39%169.66%
2003-30,649.44%2669.68%
2002-1,106.60%109.5%
2001-528.22%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-100.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
22.03%-100.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-86.06%-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
8.45%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-1,167.54%-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-16,748.00%-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.